Semi-Annual Statement Of Income And Retained Earnings

COSMOS Pharmaceutical Corporation - Filing #7734333

Concept	2016-06-01 to 2017-05-31	2016-06-01 to 2017-05-31	2016-06-01 to 2017-05-31	2016-06-01 to 2017-05-31	2016-06-01 to 2017-05-31	2015-06-01 to 2016-05-31	2015-06-01 to 2016-05-31	2015-06-01 to 2016-05-31	2015-06-01 to 2016-05-31	2015-06-01 to 2016-05-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)	—	—	22,237,000,000 JPY	—	22,202,000,000 JPY	—	18,648,000,000 JPY	18,626,000,000 JPY	—	—
Non-operating income
Non-operating income	—	—	3,243,000,000 JPY	—	3,244,000,000 JPY	—	2,778,000,000 JPY	2,774,000,000 JPY	—	—
Non-operating expenses
Non-operating expenses	—	—	889,000,000 JPY	—	887,000,000 JPY	—	734,000,000 JPY	734,000,000 JPY	—	—
Ordinary profit (loss)	—	—	24,591,000,000 JPY	—	24,559,000,000 JPY	—	20,691,000,000 JPY	20,666,000,000 JPY	—	—
Extraordinary income
Extraordinary income	—	—	1,676,000,000 JPY	—	1,676,000,000 JPY	—	518,000,000 JPY	518,000,000 JPY	—	—
Extraordinary losses
Extraordinary losses	—	—	530,000,000 JPY	—	530,000,000 JPY	—	713,000,000 JPY	713,000,000 JPY	—	—
Profit (loss) before income taxes	—	—	25,737,000,000 JPY	—	25,706,000,000 JPY	—	20,496,000,000 JPY	20,471,000,000 JPY	—	—
Income taxes - current	—	—	7,688,000,000 JPY	—	7,677,000,000 JPY	—	7,999,000,000 JPY	7,990,000,000 JPY	—	—
Income taxes - deferred	—	—	-166,000,000 JPY	—	-165,000,000 JPY	—	61,000,000 JPY	61,000,000 JPY	—	—
Profit (loss)	18,194,000,000 JPY	18,194,000,000 JPY	18,215,000,000 JPY	18,194,000,000 JPY	18,194,000,000 JPY	12,419,000,000 JPY	12,435,000,000 JPY	12,419,000,000 JPY	12,419,000,000 JPY	12,419,000,000 JPY